Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a routine version update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:18:42.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T21:17:06.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed, which appears to be an internal version update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:53:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The government funding lapse and operating-status disclaimer at the top of the page has been removed.
    Difference
    0.2%
    Check dated 2025-11-18T06:58:52.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Both screenshots show the same study details page with no added or removed content or layout changes.
    Difference
    0.3%
    Check dated 2025-11-03T21:10:40.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    - Added a government funding notice and current operating status guidance, and updated the version to v3.2.0. - Removed the Genetic and Rare Diseases Information Center resource for Small cell lung carcinoma and old version reference v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:34:48.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.